Thyroid: Iodine beyond the thyronines

Current Chemical Biology

Volumn 5, Issue 3, 2011, Pages 163-167

  Juvenal, Guillermo J ^a   Thomasz, Lisa ^a   Oglio, Romina ^a   Perona, Marina ^a   Pisarev, Mario A ^a   Rossich, Luiciano ^a   Salvarredi, Leonardo ^a  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

Author keywords

Iodine; Iodocompounds; Iodohexadecanal; Iodolactone; Iodolipids; Thyroid

Indexed keywords

2 IODOHEXADECANAL; 6 IODO DELTA LACTONE; ANTITHYROID AGENT; IODIDE; IODINE; IODINE DERIVATIVE; THYRONINE DERIVATIVE; THYROTROPIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOREGULATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HORMONE SYNTHESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; THYROID FUNCTION; THYROID GLAND;

EID: 80051717338     PISSN: None     EISSN: 18723136     Source Type: Journal    
DOI: 10.2174/187231311796765003     Document Type: Article

References (70)

1. Dumont JE, Lamy F, Roger PP. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiological Rev 1992; 72: 667-97.
2. th. ed. Braverman LE & Uitger RD, Eds., Lippincott USA, 2000; pp. 85-90.
3. Panneels V, Juvenal G, Boeynaems JM, Dumont JE, Van Sande J. Iodide effects on the thyroid: biochemical, physiological, pharmacological and clinical effects of iodide in the thyroid. comprehensive handbook on iodine: nutritional, endocrine and pathological aspects. Preedy VR, Burrow GN, Watson R, Eds, Oxford: Academic Press, 2009; pp. 303-14.
4. Chapman A. The relation of the thyroid and pituitary glands to iodine metabolism. Endocrinology 1941; 29: 680-5.
5. Bray G. Increased sensitivity of the thyroid in iodine-depleted rats to the goitrogenic effects of thyrotropin. J Clin Invest 1968; 47: 1640-7.
6. Matsuzaki S, Suzuki M. Thyroid function and polyamines. II. Thyrotropin stimulation of polyamine biosynthesis in the rat thyroid. Endocrinol Jpn 1975; 22: 339-45.
7. Berthier C, Lemarchand-Béraud T. Importance of thyroid iodine and cyclic AMP, and TSH concentrations on goitre formation in rats. Acta Endocrinol (Copenh) 1978; 89: 567-79.
8. Naeije R, Vanhaelst L, Golstein J. Pituitary-thyroid axis during short term, mild and severe, iodine depletion in the rat. Horm Metab Res 1978; 10: 521-5.
9. Pisarev MA, Utiger RD, Salvaneschi JP, Altschuler N, DeGroot LJ. Serum TSH and thyroxine in Goitrous Subjects in Argentina. J Clin Endocr 1970; 30: 680-1.
10. Hellstern P, Keller HE, Weinheimer B, Wesch H. Thyroid iodine concentration and total thyroid iodine in normal subjects and in endemic goitre subjects. Clin Endocrinol (Oxf) 1978; 9: 351-6.
11. Gérard AC, Poncin S, Caetano B, et al. Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid. Am J Pathol 2008; 172: 748-60.
12. Michalkiewicz M, Huffman LJ, Connors JM, Hedge GA. Alterations in thyroid blood flow induced by varying levels of iodine intake in the rat. Endocrinology 1989; 125: 54-60.
13. Gérard AC, Poncin S, Audinot JN, Denef JF, Colin IM. Iodide deficiency-induced angiogenic stimulus in the thyroid occurs via HIF- and ROS-dependent VEGF-A secretion from thyrocytes. Am J Physiol Endocrinol Metab 2009; 296: E1414-22.
14. Abbassi V, McKenzie JM. Lack of iodide effect on serum and pituitary thyrotropin in vivo. Endocrinology 1967; 81: 871-6.
15. Pisarev MA, Itoiz ME. Action of KI on stimulated thyroid protein biosynthesis. Endocrinology 1972; 90: 1409-12.
16. Kanno J, Nemoto T, Kasuga T, Hayashi Y. Effects of a six-week exposure to excess iodide on thyroid glands of growing and nongrowing male fischer-344 rats. Toxicol Pathol 1994; 22: 23-8.
17. Yamada E, Yamazaki K, Takano K, Obara T, Sato, K. Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: A microarray search for effects of thyrotropin and iodide on angiogenesis factors. Thyroid 2006; 16: 545-54.
18. Tramontano D, Veneziani BM, Lombardi A, Villone G, Ingbar SH. Iodine inhibits the proliferation of rat thyroid cells in culture. Endocrinology 1989; 125: 984-92.
19. Smerdely P, Pitsiavas V, Boyages SC. Evidence that the inhibitory effects of iodide on thyroid cell proliferation are due to arrest of the cell cycle at G0G1 and G2M phases. Endocrinology 1993; 133: 2881-8.
20. Morton ME, Chaikoff IL, Rosenfeld S. Inhibiting effect of inorganic iodide on the formation in vitro of thyroxine and diiodotyrosine by surviving thyroid tissue. J Biol Chem 1944; 154: 381-7.
21. Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 1948; 174: 555-64.
22. 2 availability. Horm Metab Res 1988; 20: 86-90.
23. 2 generation. Biochem Biophys Res Commun 1988; 154: 1287-92.
24. Rossich L, Thomasz L, Nicola JP, et al. Role of 2- Iodohexadecanal in the thyroid autoregulatory mechanism. Proceedings of the 14th International Thyroid Congress, Paris, France, 2010.
25. 2 generation in thyroid slices from several species. Am J Physiol Endocrinol Metab 2000; 278: E692-9.
26. DeGroot LJ, Greer MA. The effect of stable iodide on thyroid secretion in man. Metabolism 1956; 5: 682-96.
27. Pisarev MA. Thyroid autoregulation. J Endocrinol Invest 1985; 8: 475-84.
28. Uyttersprot N, Pelgrims N, Carrasco N, et al. Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid. Mol Cel Endocrinol 1997; 131: 195-203.
29. Eng PH, Cardona GR, Fang SL, et al. Escape from the acute Wolff- Chaikoff effect is associated with a decrease in thyroid sodium/ iodide symporter messenger ribonucleic acid and protein. Endocrinology 1999; 140: 3404-10.
30. Thomasz L, Oglio R, Dagrosa MA, Krawiec L, Pisarev MA, Juvenal GJ. 6 Iodo-delta-lactone reproduces many but not all the effects of iodide. Mol Cell Endocrinol 2010a; 323:161-6.
31. Eng PH, Cardona GR, Previti MC, Chin WW, Braverman LE. Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol 2001, 144:139-44.
32. Spitzweg C, Joba W, Morris JC, Heufelder AE. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid 1999; 9: 821-30.
33. Serrano-Nascimento C, Calil-Silveira J, Nunes MT. Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration. Am J Physiol Cell Physiol 2010; 298: C893-9.
34. Heywood SM. The regulation of amino acid incorporation into thyroid protein: evidence that thyroxine and iodide inhibit protein synthesis at a ribosomal site. Biochim Biophys Acta 1966; 123: 188-96
35. Pregliasco L, Bocanera, Krawiec, Pisarev M, Juvenal G. Effects of iodide on thyroglobulin biosynthesis in FRTL5 cells. Thyroid 1996; 6: 319-23.
36. De Robertis E, Nowinski WW. The mechanism of the therapeutic effect of iodine on the thyroid gland. Science 1946; 103: 421-2.
37. Filetti S, Vetri M, Damante G, Belfiore A. Thyroid autoregulation: effect of iodine on glucose transport in cultured thyroid cells. Endocrinology 1986; 118: 1395-400.
38. Filetti S, Rapoport B. Autoregulation by iodine of thyroid protein synthesis: influence of iodine on amino acid transport in cultured thyroid cells. Endocrinology 1984; 114: 1379-85.
39. Kleiman de Pisarev DL, Pisarev MA, Juvenal GJ. Action of KI and several iodocompounds on [3H]uridine incorporation into thyroid RNA. Acta Endocrinol (Copenh) 1978; 89: 316-22.
40. Franzen A, Piek E, Westermark B, Ten Dijke P, Heldin NE. Expression of transforming growth factor B1, Activin A and their receptors in thyroid follicle cells: negative regulation of thyroid growth and function. Endocrinology 1999; 140: 4300-10.
41. Cowin AJ, Davis JRE, Bidey SP. Transforming growth factor b1 production in porcine thyroid follicular cells: regulation by intrathyroidal organic iodine. J Mol Endocrinol 1992; 9: 197-205.
42. Pisarev MA, Thomasz L, Juvenal GJ. Role of TGF-β in the regulation of thyroid function and growth under normal and abnormal conditions. Thyroid 2009; 19: 881-92.
43. Yuasa R, Eggo MC, Meinkoth J, Dillmann WH, Burrow GN. Iodide induces TGF-β1mRNA in sheep thyroid cells. Thyroid 1992; 2: 141-5.
44. Grubeck Loebenstein B, Buchan G, Sadeghi R, et al. Transforming growth factor beta regulates thyroid growth. J Clin Invest 1989; 83: 764-70.
45. Gärtner R, Schopohl D, Schaefer S. Regulation of TGF-β1 mRNA expression in porcine thyroid follicles in vitro by growth factors, iodine or δ-iodolactone. Thyroid 1997; 4: 633-40.
46. Van Sande J, Grenier G, Willems C, Dumont JE. Inhibition by iodide of the activation of the thyroid cyclic 3',5'-AMP system. Endocrinology 1975; 96: 781-6.
47. Lissitzky S, Gregoire J, Gregoire J, Limozin N. The presence and in vitro activity of free iodinated peptides in the thyroid gland of mammals and man. Gen Comp Endocrinol 1961; 1: 519-33.
48. Juvenal GJ, Pisarev MA, Kleiman de Pisarev DL, Altschuler N. Uptake, metabolism and action of triiodothyronine in calf-thyroid slices. Mol Cell Endocrinol. 1981; 22: 31-40.
49. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev 2010; 31: 139-70.
50. Boeynaems JM, Hubbard WC. Transformation of arachidonic acid into an iodolactone by the rat thyroid. J Biol Chem 1980; 255: 9001-4.
51. Dugrillon A, Uedelhoven WM, Pisarev MA. Identification of a δ- iodolactone in iodide treated human goiter and its inhibitory effect on proliferation on human thyroid follicles. Horm Met Res 1994; 26: 465-9.
52. Pereira A, Braekman JC, Dumont JE. Identification of a major iodolipid from the horse thyroid gland as 2-iodohexadecanal. J Biol Chem 1990; 265: 17018-25.
53. Pisarev MA, Bocanera LV, Chester HA, Krawiec L, JuvenalGJ. Effect of iodoarachidonates on thyroid FRTL-5 cells growth. Horm Metab Res 1992; 24: 558-61.
54. Dugrillon A, Bechtner G, Uedelhoven WM. Evidence that an iodolactone mediates the inhibitory effect of iodine on thyroid cell proliferation but not on adenosine 3',5'-monophosphate formation. Endocrinology 1990; 127: 337-43.
55. Dugrillon A, Gartner R. Delta-Iodolactones decrease epidermal growth factor-induced proliferation and inositol-1,4,5-trisphosphate generation in porcine thyroid follicles: a possible mechanism of growth inhibition by iodide. Eur J Endocrinol 1995; 132: 735-43.
56. Langer R, Burzler C, Bechtner G, Gärtner R. Influence of iodide and iodolactones on thyroid apoptosis. Evidence that apoptosis induced by iodide is mediated by iodolactones in intact porcine thyroid follicles. Exp Clin Endocrinol Diabetes 2003; 111: 325-29.
57. Pisarev MA, Chazenbalk GD, Valsecchi RM. Thyroid autoregulation. Inhibition of goiter growth and of cAMP formation in rat thyroid by iodinated derivatives of arachidonic acid. J Endocrinol Invest 1988; 1: 669-74.
58. Pisarev MA, Krawiec L, Juvenal GJ. Studies on the goiter inhibiting effects of iodolactones. Eur J Pharmacol 1994; 258: 33-7.
59. Chazenbalk GD, Valsecchi RM, Krawiec L, et al. Thyroid autoregulation inhibitory effects of iodinated derivatives of arachidonic acid in iodine metabolism. Prostaglandins 1988; 36: 163-72.
60. Krawiec L, Chester HA, Bocanera LV, Pregliasco LB, Juvenal GJ, Pisarev MA. Thyroid autoregulation: evidence for an action of iodoarachidonates and iodide at the cell membrane level. Horm Metab Res 1991; 23: 321-5.
61. Thomasz L, Oglio R, Randi AS, et al. Biochemical changes during goiter induction by methylmercaptoimidazol and inhibition by delta-iodolactone in rat. Thyroid 2010b; 20: 1003-13.
62. Shrivastava A, Tiwari M, Sinha RA, et al. Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. J Biol Chem 2006; 281: 19762-71.
63. Arroyo-Helguera O, Anguiano B, Delgado G, Aceves C. Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line. Endocr Relat Cancer 2006; 13: 1147-58.
64. Nuñez-Anita RE, Arroyo-Helguera AO, Cajero-Juárez M, López- Bojorquez L, Aceves C. Complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplasic effect of iodine in mammary cancer. Prost Lipid Med 2009; 89: 34-42
65. Rösner H, Torremante P, Möller W, Gärtner R. Antiproliferative/ cytotoxic activity of molecular iodine and iodolactones in various human carcinoma cell lines. No interfering with EGFsignaling, but evidence for apoptosis. Exp Clin Endocrinol Diabetes 2010; 118: 410-19.
66. Panneels V, Macours P, Van der Bengen H. Biosynthesis and metabolism of 2-iodohexadecanal in cultured dog thyroid cells. J Biol Chem 1996; 271: 23006-14.
67. Ohayon R, Boeynaems JM, Braekman JC, Van den Bergen H, Gorin Y, Virion A. Inhibition of thyroid NADPH oxidase by 2- iodohexadecanal in a cell-free system. Mol Cell Endocrinol 1994; 99: 133-41.
68. Panneels V, Van den Bergen H, Jacoby C, et al. Inhibition of H2O2 production by iodoaldehydes in cultured dog thyroid cells. Mol Cell Endocrinol 1994a; 102: 167-76.
69. Panneels V, Van Sande J, Van den Bergen H, et al. Inhibition of human thyroid adenylyl cyclase by 2-iodoaldehydes. Mol Cell Endocrinol 1994b; 106: 41-50.
70. Thomasz L, Oglio R, Rivandeira DT, et al. Inhibition of goiter growth and of cyclic AMP formation in rat thyroid by 2- iodohexadecanal. Mol Cell Endocrinol 2010c; 317: 141-7.